These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 15024959)
1. Positron emission tomography imaging of the aging brain. Meltzer CC; Becker JT; Price JC; Moses-Kolko E Neuroimaging Clin N Am; 2003 Nov; 13(4):759-67. PubMed ID: 15024959 [TBL] [Abstract][Full Text] [Related]
2. [Neuropharmacology and receptor studies in the elderly]. Meltzer CC Rev Neurol; 2002 Oct 16-31; 35(8):767-77. PubMed ID: 12402232 [TBL] [Abstract][Full Text] [Related]
3. Imaging of neurotransmitter receptors in the living human brain by positron emission tomography (PET). Yanai K; Watanabe T; Itoh M; Ido T J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():581-4. PubMed ID: 1338452 [TBL] [Abstract][Full Text] [Related]
5. TechSight. Imaging. A molecular map for neurodegeneration. Marek K; Seibyl J Science; 2000 Jul; 289(5478):409-11. PubMed ID: 10939953 [No Abstract] [Full Text] [Related]
6. Drug development for neurodegenerative diseases: role of PET. Rinne JO Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860 [TBL] [Abstract][Full Text] [Related]
7. The use of positron emission tomography in cerebrovascular disease. Powers WJ; Zazulia AR Neuroimaging Clin N Am; 2003 Nov; 13(4):741-58. PubMed ID: 15024958 [TBL] [Abstract][Full Text] [Related]
8. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Silverman DH; Phelps ME Mol Genet Metab; 2001; 74(1-2):128-38. PubMed ID: 11592810 [No Abstract] [Full Text] [Related]
10. Neuropharmacology and receptor studies in the elderly. Meltzer CC J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702 [TBL] [Abstract][Full Text] [Related]
11. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias]. Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195 [TBL] [Abstract][Full Text] [Related]
12. [The role of positron emission tomography in neuropharmacology in the living human brain and drug development]. Yanai K Nihon Yakurigaku Zasshi; 1999 Sep; 114(3):169-78. PubMed ID: 10553580 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of the drawbacks of single photon emission computed tomography and positron emission tomography imaging]. Mizumura S Brain Nerve; 2010 May; 62(5):489-500. PubMed ID: 20450096 [TBL] [Abstract][Full Text] [Related]
14. The expanding role of imaging in prion disease. Taber KH; Cortelli P; Staffen W; Hurley RA J Neuropsychiatry Clin Neurosci; 2002; 14(4):371-6. PubMed ID: 12426406 [No Abstract] [Full Text] [Related]
15. Measurement of neurotransmitter receptors by positron emission tomography: focus on the opiate receptor. Frost JJ NIDA Res Monogr; 1986; 74():15-24. PubMed ID: 2827031 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography of the brain. Jamieson DG; Greenberg JH Comput Med Imaging Graph; 1989; 13(1):61-79. PubMed ID: 2647282 [TBL] [Abstract][Full Text] [Related]
17. [Visualization of neurotransmitter receptors in the living human brain by position emission tomography (PET)]. Yanai K; Watanabe T Nihon Yakurigaku Zasshi; 1994 Feb; 103(2):49-58. PubMed ID: 8112689 [TBL] [Abstract][Full Text] [Related]
18. Measurement of local cerebral blood flow and metabolism in man with positron emission tomography. Raichle ME Fed Proc; 1981 Jun; 40(8):2331-4. PubMed ID: 6972328 [TBL] [Abstract][Full Text] [Related]